Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE0005785802
Sun, 30.10.2022
Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care revises financial outlook for full year 2022 due to delayed effects from improvements in North American Services business in challenging environment
Business development continues to be strongly impacted by highly uncertain macroeconomic environment driving wage and general cost inflation in all reporting segments
Im [ … ]
Sun, 30.10.2022
Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care revises financial outlook for full year 2022 due to delayed effects from improvements in North American Services business in challenging environment
Business development continues to be strongly impacted by highly uncertain macroeconomic environment driving wage and general cost inflation in all reporting segments
Im [ … ]
Sun, 30.10.2022
Fresenius Medical Care AG & Co. KGaA
Since Fresenius Medical Care continues to operate in a challenging environment, the impacts of the Company’s focused efforts to improve North American Health Care Services operations are delayed against previous assumptions. Therefore, Fresenius Medical Care now assumes lower contributions in the financial year 2022.
Consequently, Fresenius Medica [ … ]
Sun, 30.10.2022
Fresenius Medical Care AG & Co. KGaA
Since Fresenius Medical Care continues to operate in a challenging environment, the impacts of the Company’s focused efforts to improve North American Health Care Services operations are delayed against previous assumptions. Therefore, Fresenius Medical Care now assumes lower contributions in the financial year 2022.
Consequently, Fresenius Medica [ … ]
Wed, 27.07.2022
Fresenius Medical Care AG & Co. KGaA
In the second quarter Fresenius Medical Care experienced increasing different headwinds that are now expected to negatively impact the Company´s earnings development in the second half of FY 2022 to a significant larger degree than anticipated when giving guidance. Earnings development in particular is anticipated to be affected by increased wage i [ … ]
Wed, 27.07.2022
Fresenius Medical Care AG & Co. KGaA
In the second quarter Fresenius Medical Care experienced increasing different headwinds that are now expected to negatively impact the Company´s earnings development in the second half of FY 2022 to a significant larger degree than anticipated when giving guidance. Earnings development in particular is anticipated to be affected by increased wage i [ … ]
Wed, 04.05.2022
Fresenius Medical Care AG & Co. KGaA
- Higher than anticipated COVID-19-related excess mortality, but declining throughout the quarter
- Earnings development affected by ongoing significantly elevated labor costs compounded by effects from Omicron in Health Care Services and by increased material and logistics costs in Health Care Products
- Earnings development in EMEA additionally [ … ]
Tue, 03.05.2022
Fresenius Medical Care AG & Co. KGaA
Dr. Carla Kriwet (51) will become the new CEO of Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, on January 1, 2023. The Supervisory Board of Fresenius Medical Care Management AG unanimously appointed her to succeed Rice Powell (66), who in accordance with the company’s age limit fo [ … ]
Tue, 03.05.2022
Fresenius Medical Care AG & Co. KGaA
In today’s meeting the Supervisory Board of Fresenius Medical Care's General Partner unanimously appointed Dr. Carla Kriwet as CEO of the Management Board effective January 1, 2023. Dr. Carla Kriwet succeeds Rice Powell, who will step down from the Management Board in light of the age limit for members of the Management Board when his contract expi [ … ]
Mon, 21.03.2022
Fresenius Medical Care AG & Co. KGaA
- Creation of new company combines strengths of three leading value-based care specialists
- Execution on strategic expansion along the renal care continuum significantly expands Fresenius Medical Care's total addressable market in the U.S. from around $50 billion to around $170 billion
- Establishing independent and integrated value-based care off [ … ]